1-2 of 2
Fatima Talab, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

REDX08608, a Novel, Potent and Selective, Reversible BTK Inhibitor with Efficacy and Equivalent Potency Against Wild-Type and Mutant C481S BTK

Nicolas E. S. Guisot, PhD, Stuart A. Best, PhD, Victoria Wright, PhD, Andrew Thomason, Jennifer A. Woyach, MD, Rose Mantel, Fabienne McClanahan, MD PhD, Valentina Abet, PhD, Diana Castagna, PhD, Peggy Cousin, MSc, Juliette Emmerich, MSc, Kelvin Ho, PhD, James Russell Kelly, MSc, James King-Tours, MSc, Kristina Lyons, MSc, Melanie Muller, PhD, Julienne Refuerzo, Louise Sargent, MSc, Fatima Talab, PhD, Matilda Bingham, PhD, Caroline Phillips, PhD, Richard Armer, PhD
Journal: Blood
Blood (2016) 128 (22): 4399.
https://doi.org/10.1182/blood.V128.22.4399.4399
Published: 2016
Journal Articles

Development of REDX05194, a Novel, Potent and Selective Inhibitor of Bruton's Tyrosine Kinase (BTK) As a Potential Treatment for B-Cell Malignancies

Victoria Walker, PhD, Nicolas E S Guisot, PhD, Stuart Best, PhD, Fatima Talab, PhD, Catherine L Lucas, PhD, Julienne Refuerzo, Mathew Calder, Lauren Proctor, Melanie Muller, PhD, Kelvin Ho, PhD, Rose Chappell, Juliette Emmerich, PhD, Shona Harmon, PhD, Matilda Bingham, PhD, Mary-Ann Campbell, PhD, Richard Armer, PhD
Journal: Blood
Blood (2015) 126 (23): 4848.
https://doi.org/10.1182/blood.V126.23.4848.4848
Published: 2015